This company has shut down. Turnstone Biologics is no longer operating — its last tracked round was a Series D in 2021.
Explore the Startup GraveyardTurnstone Biologics is a privately-held clinical stage biotech company.
Turnstone Biologics has raised $80.0M in total funding. The most recent round was Series D. The last funding was announced in July 2021.
Turnstone Biologics's investors include Point72, OrbiMed, Northleaf Capital Partners, Takeda, Versant Ventures.
Turnstone Biologics is headquartered in La Jolla, United States.
Turnstone Biologics is a privately-held clinical stage biotech company.
Turnstone Biologics is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Turnstone Biologics — Funding & Investors." VCBacked, July 14, 2021, https://www.vcbacked.co/company/turnstone-biologics. Accessed September 29, 2026.
VCBacked. (2021). Turnstone Biologics — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/turnstone-biologics
{{cite web |title=Turnstone Biologics — Funding & Investors |url=https://www.vcbacked.co/company/turnstone-biologics |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated